Drug · DIN 02394766
APO-OXYCODONE CR
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since November 27, 2012; first marketed November 27, 2012.
- Drug Identification Number (DIN)
- 02394766
- Company (DIN owner)
- Apotex Inc.Toronto, Ontario, Canada
- Schedule
- Narcotics (CDSA I)
- Dosage form
- Tablet (Extended-Release)
- Route
- Oral
- Therapeutic class (ATC)
- Oxycodone N02AA05
- Class
- Human
- Record last updated
- June 12, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| OXYCODONE HYDROCHLORIDE | 15 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- November 26, 2012: NOC 13891Supplement to an Abbreviated New Drug Submission (SANDS) · New Strengths
Recalls and safety alerts that mention it
Health Canada’s recall notices do not carry licence numbers, so these are matched by name: notices whose title or product names “apo-oxycodone”. A notice may cover another product or only some lots: read it to see what it covers.
- Apo-Oxycodone CR (2013-10-28)November 21, 2013 · Drugs · Product safety · Type III
Other DINs named APO-OXYCODONE CR
- DIN 02306530 · Marketed
- DIN 02366746 · Marketed
- DIN 02366754 · Marketed
- DIN 02366762 · Marketed
- DIN 02366789 · Marketed
- DIN 02394774 · Marketed
- DIN 02394782 · Marketed